IMR Press / FBL / Volume 9 / Issue 1 / DOI: 10.2741/1283

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article

Cyclosal-pronucleotides—development of first and second generation chemical trojan horses for antiviral chemotherapy

Show Less
1 Institute of Organic Chemistry, University of Hamburg, Martin-Luther-King-Platz 6; D-20146 Hamburg, Germany
2 Institute for Virology and Antiviral Therapy, Friedrich-Schiller-University Jena, Winzerlaer Straße 10, D-07745 Jena, Germany
3 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium
Front. Biosci. (Landmark Ed) 2004, 9(1), 873–890; https://doi.org/10.2741/1283
Published: 1 January 2004
Abstract

Pronucleotides represent a promising alternative to improve the biological activity of nucleoside analogs against different viral diseases. Moreover, pronucleotides are valuable tools for studies concerning the nucleoside/nucleotide metabolism. The basic idea is to achieve nucleotide delivery into cells, bypassing limitations with intracellular formation of nucleotides from their nucleoside precursors. The cycloSal-concept is one of several pronucleotide systems reported so far but is the only approach in which a pronucleotide is cleaved successfully by a simple but selective chemical hydrolysis. Beside others, for the nucleoside analog d4T the application of the cycloSal-approach improved antiviral potency. In the first part, the basic concept, the chemistry, different structural modifications and their effects on the antiviral potency of the cycloSal-d4TMP triesters have been discussed in this review. In the second part, first results of a conceptional extension of the original cycloSal-approach will be summarized. Once the pronucleotides have passed the membrane, the aim is to trap the cycloSal-phosphate triesters inside the cells. Therefore, enzyme-cleavable groups have been attached via a linker to the cycloSal-moiety.

Keywords
Virus
Treatment
Therapy
Drug
Nucleoside Analogs
Prodrug
Pronucleotide
CycloSal-Pronucleotides
Antiviral Chemotherapy
Review
Share
Back to top